Register to get 1 free article
Reveal the article below by registering for our email newsletter.
Want unlimited access? View Plans
Already have an account? Sign in
Private equity firm Inflextion has revealed that it has sold its stake in pet supplement company Lintbells to Vetnique Labs, backed by Gryphon Investors.
Since the 2017 investment, Inflexion’s in-house teams have supported Lintbells across a range of growth opportunities.
This includes its expansion of the direct-to-consumer channel as well as the expansion of Lintbells into the US and acquisition of Walkin’ Pets.
The investment period also facilitated the planned succession of co-founder John Howie, who set the business up in 2006, with Fiona Hope brought in as chief commercial officer.
Hope went on to become chief executive of the business in 2022.
Malcolm Coffin, partner and head of Inflexion’s Enterprise Fund, said: “Lintbells has achieved tremendous growth during our investment, and we are particularly proud to have supported their successful entry into the US market. We wish Fiona and the team all the very best for the continued growth of the business.”
Hope added: “Lintbells’ journey over the last few years has been one of high-quality growth. Inflexion’s backing and partnership enabled us not only to achieve our goals more quickly but to aspire to even greater ones. Their network was invaluable in expanding our digital capabilities and bringing our supplements to the US.“
